PPARG and Insulin resistance: Under systemic conditions in a mouse model, the adipocyte-specific MED19 knock-down in adipose tissue leads to lipodystrophy, hepatic steatosis and insulin resistance which is associated with a change in the PPARγ-mediated gene expression, but also with beiging of BAT [83].